WB
IHE icon

Webster Bank’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Webster Bank’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-249
Closed -$12K – 578
2016
Q4 		$12K Buy
+249
New +$11.8K ﹤0.01% 495

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RTS
Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Webster Bank's IHE Position: Q1 2017 in Review

Webster Bank sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2017, closing a stake of 249 shares — an estimated $12K sold.

Webster Bank first reported a position in IHE in Q4 2016 and held it in 1 quarter. The position peaked at $12K in Q4 2016. 97 funds tracked by Wall St. Rank hold IHE as of Q1 2017.

  • Webster Bank reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
  • Webster Bank sold 249 iShares US Pharmaceuticals ETF shares in Q1 2017, an estimated $12K.
  • Webster Bank first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and held it in 1 quarter.
  • Webster Bank's iShares US Pharmaceuticals ETF position peaked at $12K in Q4 2016.
  • 97 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2017.

Based on Webster Bank's 13F filing for Q1 2017, filed 1 May 2017.